Relenza warning after patient dies turning flu powder into liquid
The drug company GlaxoSmithKline said that at least one person has died after turning its anti-flu powder Relenza into a liquid.[emphisis added]
In a letter to doctors, GSK said reformulation was not recommended by the Food and Drug Administration in the US. The FDA posted the letter online yesterday without providing details of the person who died.
Relenza comes in powder form for use with Glaxo’s Diskhaler device. The drug is approved to treat symptoms of the seasonal flu when taken within two days of onset.
The FDA and London-based GSK have stressed that reconstituting Relenza has not been established as safe.
Swine flu vaccine victims encouraged to post reports of side effects here:
SwineFluVaccineReport.
This site was created by Mike Adams, NaturalNews editor. Read more
HERE.
Related Post:
